Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry Meeting Abstract
| Authors: | Bezerra, E.; Itani, T.; Wudhikarn, K.; Perales, M. A.; Yang, Y.; Gergis, U.; Aribi, A.; Hill, L. C.; Jain, N.; Leonard, J. T.; Lutfi, F.; Kim, S.; Bye, M.; Wang, H. L.; Hadjivassileva, T.; Nikolaenko, L.; Kloos, I.; Abdeldaim, A.; Dalton, D.; Xu, H. R.; Pasquini, M.; Kebriaei, P. |
| Abstract Title: | Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1029 |
| Language: | English |
| ACCESSION: | WOS:001159306704053 |
| DOI: | 10.1182/blood-2023-177693 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work